Daniel Kass
Physician · Upmc
Credentials: · · · · ·
History
Research
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
European Respiratory Journal · 2019 · 680 citations
Circulation · 2016 · 329 citations
A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults
Environmental Health Perspectives · 2007 · 208 citations
36 papers
19 papers
- CR
12 papers
10 papers
10 papers
10 papers
- JM
9 papers
- KJ
9 papers
Grants
- 2025–2028
E-Box Accessibility in Myofibroblasts in Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.5M · University of Pittsburgh at Pittsburgh
- 2017–2024
Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · U01
PI · $3.8M · University of Alabama at Birmingham
- 2014–2020
Rituximab Therapy in Patients with IPF
National Heart, Lung, and Blood Institute · R01
PI · $2.7M · University of Alabama at Birmingham
- 2015–2020
Twist1 Subphenotypes and Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.9M · University of Pittsburgh at Pittsburgh
Clinical trials
- 2014–2017
Principal investigator · Completed
New York City Department of Health and Mental Hygiene
- 2018–2028
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Sub-investigator · Recruiting · Phase 2
Paul Szabolcs
- 2005–2030
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Sub-investigator · Recruiting
University of Pittsburgh
- 2003–2035
Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Sub-investigator · Recruiting
University of Pittsburgh